Propyl Gallate Injection

1. Pharmacological action This product has the effect of inhibiting platelet aggregation caused by (thromboxane A2) TXA2; it can reduce whole blood viscosity and plasma specific viscosity, accelerate the electrophoresis of red blood cells, relax vascular smooth muscle, increase coronary blood flow; it has a significant protective effect on myocardial ischemia. 2. Toxicity study In acute toxicity experiments, the LD50 of intravenous injection in mice is 311.13mg/kg±5.31mg/kg. Subacute toxicity experiments show that this product has no significant effect on liver and kidney function. The Ames test is negative.

The main ingredient of this product is propyl gallate

Used to prevent and treat cerebral thrombosis, coronary heart disease and complications of surgical operations - deep thrombotic vein inflammation, etc.

1. Slow intravenous drip. Once a day, 120-180 mg each time, 10-15 days as a course of treatment. 2. The specification of this product is 250ml: 120 mg, please use it according to the doctor's advice.

A small number of patients may experience a transient slowing of heart rate or a slight increase in alanine aminotransferase after intravenous infusion, which may return to normal on their own within 1 to 2 weeks of discontinuation of the drug.

It is contraindicated for those who are allergic to any ingredient of this product.

Not yet clear

Keep away from light and store in a sealed container.

10ml:0.18g

Huarun Shuanghe Limin Pharmaceutical (Ji'nan) Co., Ltd.

• Founded in:

  2001-06-28

• Address:

  No. 1, Limin Road, Mingshui Street, Zhangqiu District, Jinan City, Shandong Province

• Tax NO.:

  91370181163446867C

• Registered Funds:

  23.85 million yuan

• Email:

  Log in to view